Heart Test Laboratories (HSCS)

• Market cap: $3.63M
• 1 day: -2.89%
• 5 days: 0.82%
• 1 month: 12.80%
• 3 months: -23.71%
• 6 months: -26.88%
• Year to date: -77.87%
• 1 year: -77.87%
• 5 years: -97.82%
• 10 years: -97.82%
• Sector: Healthcare
• Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies

About: HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

Employees: 12

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

0.47% less ownership

Funds ownership: 1.9% [Q2] → 1.43% (-0.47%) [Q3]

5% less capital invested

Capital invested by funds: $65.3K [Q2] → $61.9K (-$3.42K) [Q3]

14% less funds holding

Funds holding: 7 [Q2] → 6 (-1) [Q3]

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $12 224% upside
• Avg. target: $12 224% upside
• High target: $12 224% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Maxim Group Allen Klee 47% 1-year accuracy 7 / 15 met price target

224% upside $12

Buy Reiterated

18 Dec 2024